AOA Dx (YC Summer 2021)

TL;DR: AOA Dx is a Y Combinator Summer 2021 startup Blood Test for Early Detection of Ovarian Cancer , currently active with a team of 25.

Blood Test for Early Detection of Ovarian Cancer

YC ID
23884
YC Batch
Summer 2021
Status
Active
Team size
25
Industry
Healthcare, Diagnostics
Tags
Healthcare, Diagnostics, Women's Health
YC profile
https://www.ycombinator.com/companies/aoa-dx-inc

Last verified:

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is AOA Dx a YC (Y Combinator) company?

Yes. AOA Dx was funded by Y Combinator in the Summer 2021 batch. Blood Test for Early Detection of Ovarian Cancer

What does AOA Dx do?

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

What YC batch was AOA Dx in?

AOA Dx was part of Y Combinator's Summer 2021 batch.

How big is AOA Dx?

AOA Dx has a team of 25 people according to Y Combinator's directory.

Is AOA Dx still active?

AOA Dx is currently listed as Active with a team of 25 in Y Combinator's directory.

More YC Summer 2021 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…